Krystal Biotech Total Liabilities and Share Holders Equity 2017-2024 | KRYS
Krystal Biotech total liabilities and share holders equity for the quarter ending June 30, 2024 was $0.918B, a 34.16% increase year-over-year.
- Krystal Biotech total liabilities and share holders equity for 2023 was $0.818B, a 46.54% increase from 2022.
- Krystal Biotech total liabilities and share holders equity for 2022 was $0.558B, a 10.83% decline from 2021.
- Krystal Biotech total liabilities and share holders equity for 2021 was $0.626B, a 101.48% increase from 2020.